The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study

2017-12-08

Blood Advances , Volume 1 p. 86- 89

Additional Metadata
Persistent URL	doi.org/10.1182/bloodadvances.2017GS102419, hdl.handle.net/1765/120294
Journal	Blood Advances
Organisation	Department of Hematology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Da Silva, F.B. (Fernanda Borges), De Figueiredo-Pontes, L.L. (Lorena Lobo), Madeira, M.I.A. (Maria Isabel Ayrosa), De Araujo Koury, L.C. (Luisa Corr Êa), De Lima, A.S.G. (Ana Silvia Gouvêa), Scheucher, P.S. (Priscila Santos), … Traina, F. (Fabiola). (2017). The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study. Blood Advances, 1, 86–89. doi:10.1182/bloodadvances.2017GS102419

Publication